Synergistic antifungal activity of berberine derivative B-7b and fluconazole.

Our previous study demonstrated berberine (BBR) and fluconazole (FLC) used concomitantly exhibited a synergism against FLC-resistant Candida albicans in vitro. We also suggested BBR played a major antifungal role in the synergism of FLC and BBR, while FLC increased intracellular BBR concentrations....

Full description

Bibliographic Details
Main Authors: Li Ping Li, Wei Liu, Hong Liu, Fang Zhu, Da Zhi Zhang, Hui Shen, Zheng Xu, Yun Peng Qi, Shi Qun Zhang, Si Min Chen, Li Juan He, Xin Ju Cao, Xin Huang, Jun Dong Zhang, Lan Yan, Mao Mao An, Yuan Ying Jiang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4438075?pdf=render
_version_ 1828832745456926720
author Li Ping Li
Wei Liu
Hong Liu
Fang Zhu
Da Zhi Zhang
Hui Shen
Zheng Xu
Yun Peng Qi
Shi Qun Zhang
Si Min Chen
Li Juan He
Xin Ju Cao
Xin Huang
Jun Dong Zhang
Lan Yan
Mao Mao An
Yuan Ying Jiang
author_facet Li Ping Li
Wei Liu
Hong Liu
Fang Zhu
Da Zhi Zhang
Hui Shen
Zheng Xu
Yun Peng Qi
Shi Qun Zhang
Si Min Chen
Li Juan He
Xin Ju Cao
Xin Huang
Jun Dong Zhang
Lan Yan
Mao Mao An
Yuan Ying Jiang
author_sort Li Ping Li
collection DOAJ
description Our previous study demonstrated berberine (BBR) and fluconazole (FLC) used concomitantly exhibited a synergism against FLC-resistant Candida albicans in vitro. We also suggested BBR played a major antifungal role in the synergism of FLC and BBR, while FLC increased intracellular BBR concentrations. Our following systematic structural modification and reconstruction of BBR core identified the novel scaffold of N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2-(substituted phenyl)acet-amide derivatives 7a-i, including B-7b and B-7d exhibiting remarkable synergistic antifungal activity and low cytotoxicity. Here, the study mainly investigated the synergistic activity of FLC and B-7b and the underlying mechanism. In vitro interaction of FLC and B-7b was investigated against 30 FLC-resistant clinical isolates of C. albicans and non-C. albicans species, including Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei and Cryptococcus neoformans. The potent synergistic activity of B-7b in combination with FLC against FLC-resistant C. albicans was found through the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed its better synergism with FLC. And as expected, B-7b exhibited much lower cytotoxicity than BBR to human umbilical vein endothelial cells. In contrast to BBR, we found that endogenous ROS augmentation was not involved in the synergism of FLC and B-7b. According to the results from our present comparative proteomic study, it seemed that the disruption of protein folding and processing and the weakening of cells' self-defensive ability contributed to the synergism of FLC and B-7b. Together, these results suggested novel scaffold BBR derivative B-7b could be a promising synergist in combination with FLC for the treatment of invasive fungal infections.
first_indexed 2024-12-12T17:00:31Z
format Article
id doaj.art-8d58d315ced842f3befa5ef73a1853e6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T17:00:31Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8d58d315ced842f3befa5ef73a1853e62022-12-22T00:18:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012639310.1371/journal.pone.0126393Synergistic antifungal activity of berberine derivative B-7b and fluconazole.Li Ping LiWei LiuHong LiuFang ZhuDa Zhi ZhangHui ShenZheng XuYun Peng QiShi Qun ZhangSi Min ChenLi Juan HeXin Ju CaoXin HuangJun Dong ZhangLan YanMao Mao AnYuan Ying JiangOur previous study demonstrated berberine (BBR) and fluconazole (FLC) used concomitantly exhibited a synergism against FLC-resistant Candida albicans in vitro. We also suggested BBR played a major antifungal role in the synergism of FLC and BBR, while FLC increased intracellular BBR concentrations. Our following systematic structural modification and reconstruction of BBR core identified the novel scaffold of N-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-2-(substituted phenyl)acet-amide derivatives 7a-i, including B-7b and B-7d exhibiting remarkable synergistic antifungal activity and low cytotoxicity. Here, the study mainly investigated the synergistic activity of FLC and B-7b and the underlying mechanism. In vitro interaction of FLC and B-7b was investigated against 30 FLC-resistant clinical isolates of C. albicans and non-C. albicans species, including Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida krusei and Cryptococcus neoformans. The potent synergistic activity of B-7b in combination with FLC against FLC-resistant C. albicans was found through the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed its better synergism with FLC. And as expected, B-7b exhibited much lower cytotoxicity than BBR to human umbilical vein endothelial cells. In contrast to BBR, we found that endogenous ROS augmentation was not involved in the synergism of FLC and B-7b. According to the results from our present comparative proteomic study, it seemed that the disruption of protein folding and processing and the weakening of cells' self-defensive ability contributed to the synergism of FLC and B-7b. Together, these results suggested novel scaffold BBR derivative B-7b could be a promising synergist in combination with FLC for the treatment of invasive fungal infections.http://europepmc.org/articles/PMC4438075?pdf=render
spellingShingle Li Ping Li
Wei Liu
Hong Liu
Fang Zhu
Da Zhi Zhang
Hui Shen
Zheng Xu
Yun Peng Qi
Shi Qun Zhang
Si Min Chen
Li Juan He
Xin Ju Cao
Xin Huang
Jun Dong Zhang
Lan Yan
Mao Mao An
Yuan Ying Jiang
Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
PLoS ONE
title Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
title_full Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
title_fullStr Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
title_full_unstemmed Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
title_short Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
title_sort synergistic antifungal activity of berberine derivative b 7b and fluconazole
url http://europepmc.org/articles/PMC4438075?pdf=render
work_keys_str_mv AT lipingli synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT weiliu synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT hongliu synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT fangzhu synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT dazhizhang synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT huishen synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT zhengxu synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT yunpengqi synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT shiqunzhang synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT siminchen synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT lijuanhe synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT xinjucao synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT xinhuang synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT jundongzhang synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT lanyan synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT maomaoan synergisticantifungalactivityofberberinederivativeb7bandfluconazole
AT yuanyingjiang synergisticantifungalactivityofberberinederivativeb7bandfluconazole